GNNSF

PINK Genscript Biotech Corporation
Nov 21, 2026 · 1:05 AM ET EOD Market Closed

$3.53 ↓ -0.25 (-6.61%) Trading Down from the previous close of $3.78, and at the day’s high of $3.53

YTD change
+20.48%
vs 20-day SMA
-27.24%
vs 200-day SMA
N/A

Price ranges

Previous day
$3.77 $3.78
open $3.77 close $3.78
+$0.01 (+0.27%)
Today
$3.53 $3.53
open $3.53 now $3.53
+$0.00 (+0.11%)
Past week
$3.77 $4.50
from $4.50 now $3.53
-$0.97 (-21.56%)
Past month
$3.77 $6.55
from $5.35 now $3.53
-$1.82 (-34.02%)
This year
$1.30 $6.55
from $2.93 now $3.53
+$0.60 (+20.48%)

Price & Performance

+1.93 (+120.62%) / 6M

$1.11$2.99$4.86$6.74May 28Sep 10Nov 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 46.1% away from all-time highs of $6.55
  • GNNSF is up 20% since the beginning of the year
  • GNNSF is up 20% over the past 12 months
  • GNNSF is down 34% over the past 1 month
  • 1% of all GNNSF investors are betting against GNNSF

GNNSF reads poor: the 12-month move is +66.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta 1.90

Balance sheet & scale

IncomeN/A
Revenue$845.0M
Cash$831.3M
Debt$344.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $7.9B

Genscript Biotech Corp. operates as a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Life-science Services and Products, Biologics Development Services, and Industrial Synthetic Biology Products. The Life-science Services and Products segment provides research services and products used for life-science research and application. The Biologics Development Services segment focuses on services aimed to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and CGT products with an integrated platform. The Industrial Synthetic Biology Products segment comprises of industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Hong Kong.

Competitor comparison

TickerCompany PriceChange
ARGNF argenx SE $965.00 N/A
PVLA Palvella Therapeutics, Inc. $142.85 -2.00%
GLXY Galaxy Digital Inc. Class A $11.22 -8.93%
ATGGF Actinogen Medical Limited $0.3300 N/A
CLRPF Clarity Pharmaceuticals Ltd. $1.20 -4.02%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.